摘要 |
<p>Disclosed herein is a use of a compound of formula (I) or a pharmaceutically acceptable salt, solvate or stereoisomer thereof, for the manufacture of a medicament for the treatment of prostrate cancer, metastatic melanoma and multiple myeloma, wherein the medicament is administered cyclically.</p> |